dr. komrokji at the h. lee moffitt cancer center in tampa. >> dr. kji had become familiar with a study in which pegylated interferon was being used with some good results. some of the literature is so positive on it that the minute i heard about it, i asked dr. komrokji if it was okay with him, i'd like to participate. >> patients have to be active. they will be offered different treatment options. they have some time to weigh on what they want to do. >> mcfarland: use of pegylated interferon, or interferon "a", has been show to hinder the progression of early-stage myelofibrosis. the side effects of this treatment can be difficult. >> the first two or three days after the shot can be very hard. but, you know, it did make my spleen shrink, and sometimes it would actually boost my energy, make me more ambitious. well, i think i can just say it this way, that i'm optimistic. something could happen that would change that, you know. but either way, i've had a great year. i've been able to do things i probably wouldn't have been able to do. and i just tak